The layer that reads every protocol—so your team never has to. Not a registry. Not a CT.gov skin. Not a site-selection report.
The way the science actually works—no NCT numbers required.
Every amendment, current to the minute.
Not buried in a 200-page PDF.
Same source of truth, same language.
Interactive sample — change the filters to see how physicians find open cohorts in seconds. The live platform reflects your institution's real open trials and slots.
Matched against eligibility logic, not keywords — variant, line of therapy, and ECOG all considered.
Modern oncology trials don't enroll "lung cancer." They enroll EGFR Exon 20 insertion, 1L, ECOG 0–1. TrialPulse maps each patient's molecular profile to the precise eligibility logic of every open study — so the right trial surfaces the moment it's relevant.
expansion
A trial being "open" means nothing if the arm your patient qualifies for is already full. TrialPulse tracks cohort- and arm-level capacity in real time — open slots, soft-closed arms, and cohorts opening next month — so no one chases a trial that can't actually take the patient.
The average oncology protocol is amended four to nine times. Each change ripples across eligibility, dosing, and visits — and takes weeks to reach every site. TrialPulse detects exactly what changed against the prior version, routes it to the right people by role and site, and verifies they understood it.
"What's the washout for prior immunotherapy?"
A 247-page protocol holds thousands of interdependent rules no one can hold in working memory. TrialPulse reads the whole document — inclusion, exclusion, dosing, washouts, concomitant meds, visit windows — and answers natural-language questions with the citation attached.
When the protocol changes, every site sees the same current truth instantly — no version confusion, no "which PDF is latest," no lag between sites in Boston, Munich, and Tokyo. One protocol, one interpretation, everywhere.
The trial existed. The cohort was open. The seat was empty. Nobody could see it.
Never miss a patient opportunity. Expand access. Grow the trial program and the precision-medicine franchise.
Every patient checked against every open cohort—automatically, at the point of care.
Stop losing eligible patients. Activate underused cohorts. Move enrollment velocity.
Sharper feasibility. Lower enrollment risk. Sites chosen for real patient access—not history.
A missed cohort isn't a missed line item. It can be the last option a patient was never offered.
We'll configure TrialPulse to your protocols and show you real open cohorts — searchable by biomarker — in 72 hours.
Tell us a little about your study and we'll tailor the demo to your protocol.